Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-03-055370
Filing Date
2003-09-29
Accepted
2003-09-29 16:32:06
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT #1 d10ka.htm 10-K/A 57805
3 RESEARCH COLLABORATION AND LICENSE AGREEMENT dex1062.htm EX-10.62 469432
4 STOCK PURCHASE AGREEMENT dex1063.htm EX-10.63 121798
5 CERTIFICATION OF CEO dex311.htm EX-31.1 9402
6 CERTIFICATION OF CFO dex312.htm EX-31.2 9420
7 CERTIFICATION OF CEO dex321.htm EX-32.1 3106
8 CERTIFICATION OF CFO dex322.htm EX-32.2 3143
  Complete submission text file 0001193125-03-055370.txt   676435
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

EIN.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-K/A | Act: 34 | File No.: 000-10824 | Film No.: 03915264
SIC: 2835 In Vitro & In Vivo Diagnostic Substances